BECTON DICKINSON & CO

BECTON DICKINSON & CO

BECTON DICKINSON & CO designs and manufactures medical devices, instruments, and reagents that physicians, hospitals, laboratories, and life science researchers rely on for safe and precise diagnostics, medication management, and bioscience discoveries; by positioning these core products at the intersection of public health, chronic care, and biopharma innovation, BDX serves institutional healthcare providers, public health agencies, and cutting-edge biotechnologies whether they are drawing blood, administering therapies, or advancing cellular analytics. With SIC roots in medical instruments and a global footprint, the company must monitor evolving FDA, EU MDR, and reimbursement regimes, negotiate supply constraints, and manage cybersecurity and quality system obligations that could affect revenue or reputational momentum, even as the latest filing remains unavailable to describe its most recent regulatory disclosures. CIK 10795 anchors this disclosure, and investors can track the ticker BDX alongside shifting policy risks; view live SEC filings on Earnings Feed.